Targeting the Nuclear Export Protein XPO1/CRM1 Reverses Epithelial to Mesenchymal TransitionAsfar S. Azmi, Ramzi M. Mohammad|Scientific Reports|2015Cited by 36
Targeting Cellular Metabolism With CPI-613 Sensitizes Pancreatic Cancer Cells to Radiation TherapyHusain Yar Khan, Asfar S. Azmi|Advances in Radiation Oncology|2022Cited by 20
Down-regulation of AR splice variants through XPO1 suppression contributes to the inhibition of prostate cancer progressionAmro Aboukameel, Asfar S. Azmi|Oncotarget|2018Cited by 17
Anticancer Efficacy of KRASG12C Inhibitors Is Potentiated by PAK4 Inhibitor KPT9274 in Preclinical Models of <i>KRAS</i> G12C-Mutant Pancreatic and Lung CancersHusain Yar Khan, Asfar S. Azmi|Molecular Cancer Therapeutics|2023Cited by 12